Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression May 8, 2026 Rebecca Shoemaker Researchers at McGill University and the Douglas Institute have unveiled groundbreaking insights into the biological underpinnings of depression, identifying two distinct types of brain cells that exhibit altered functionality in…
Psychology & Intimacy Blood Tests Tracking White Blood Cell Aging Show Promise for Identifying Depression Through Emotional and Cognitive Symptoms May 5, 2026 Rebecca Shoemaker New research offers a potential biological marker for depression, shifting focus from physical ailments to the nuanced emotional and cognitive impacts of the condition. This advancement could pave the way…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression April 30, 2026 Rebecca Shoemaker A groundbreaking study by researchers at McGill University and the Douglas Institute has unveiled critical new insights into the biological underpinnings of depression, identifying two distinct types of brain cells…
Psychology & Intimacy Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression April 23, 2026 Rebecca Shoemaker Montreal, QC – In a significant advancement for understanding one of the world’s most pervasive mental health conditions, researchers at McGill University and the Douglas Institute have identified distinct functional…
Psychology & Intimacy Parkinson’s Disease Stem Cell Therapy Trial at Keck Medicine of USC Offers Hope for Dopamine Restoration April 23, 2026 Rebecca Shoemaker Parkinson’s disease, a progressive and debilitating neurological disorder, continues to present a significant public health challenge in the United States. Affecting over one million individuals nationwide, with approximately 90,000 new…
Psychology & Intimacy Advancing Parkinson’s Treatment: Keck Medicine of USC Pioneers Stem Cell Therapy to Restore Dopamine Production April 15, 2026 Rebecca Shoemaker Parkinson’s disease, a relentless neurodegenerative disorder, impacts the lives of over one million individuals in the United States, with approximately 90,000 new diagnoses occurring annually. Characterized by its progressive nature,…
Psychology & Intimacy A Groundbreaking Stem Cell Therapy Offers New Hope in the Fight Against Parkinson’s Disease April 6, 2026 Rebecca Shoemaker Parkinson’s disease, a relentless and progressive neurodegenerative disorder, casts a long shadow over the lives of over one million individuals in the United States. Each year, approximately 90,000 new diagnoses…
Psychology & Intimacy Parkinson’s Disease Research Advances with Novel Stem Cell Therapy in Early Clinical Trials March 28, 2026 Rebecca Shoemaker Parkinson’s disease, a relentless and progressive neurological disorder affecting millions worldwide, is now the subject of a groundbreaking clinical trial exploring a novel stem cell therapy designed to directly address…
Psychology & Intimacy Keck Medicine of USC Investigates Groundbreaking Stem Cell Therapy for Parkinson’s Disease March 27, 2026 Rebecca Shoemaker Parkinson’s disease, a relentless neurodegenerative disorder, casts a long shadow over the lives of over one million Americans. Each year, approximately 90,000 new diagnoses are added to this somber statistic,…
Psychology & Intimacy A Groundbreaking Stem Cell Therapy Offers New Hope for Parkinson’s Disease Patients March 21, 2026 Rebecca Shoemaker Parkinson’s disease, a relentless neurodegenerative disorder, casts a long shadow over the lives of millions globally. In the United States alone, over one million individuals are grappling with its progressive…
